openPR Logo
Press release

Japanese Encephalitis Vaccines Market Poised for Strong Growth with Novel Vaccine Platforms

01-30-2026 07:38 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Japanese Encephalitis Vaccines Market Size

Japanese Encephalitis Vaccines Market Size

DataM Intelligence has published a new research report on "Japanese Encephalitis Vaccines Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/japanese-encephalitis-vaccines-market?kb

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Latest M & A

• Substipharm acquires the Japanese Encephalitis vaccine IMOJEV® from Sanofi, adding a marketed JE vaccine to its global portfolio - marking a significant consolidation play in JE immunization products.

Key Players:

Bharat Biotech International Limited, Valneva Austria GmbH, Sanofi, Meiji Holdings Co., Ltd., Biological E. Limited, Chengdu Institute of Biological Products Co., Ltd., Takeda Pharmaceutical Company Limited

Key Development:

Latest Japanese Encephalitis Vaccine Market Deals

• Substipharm acquires the Japanese Encephalitis vaccine IMOJEV® from Sanofi, expanding its global vaccine portfolio beyond current territories.

• Valneva and CSL Seqirus sign an exclusive marketing & distribution agreement for Valneva's JE vaccine IXIARO® in Germany, replacing the prior partner arrangement.

• Valneva secures a new supply contract with the U.S. Department of Defense (DoD) worth $32.8M for its JE vaccine IXIARO®, continuing government support for strategic stockpiles.

• SK bioscience initiates global clinical trials for its mRNA Japanese Encephalitis vaccine candidate (GBP560) with CEPI support, advancing next‐generation JE vaccine R&D.

• Vaxxas partners with SK bioscience on JE vaccine patch development under a $4.8M CEPI‐funded program, exploring novel delivery platforms for JEV immunization.

Growth Forecast Projected:

The Japanese Encephalitis Vaccines Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the Japanese Encephalitis Vaccines Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=japanese-encephalitis-vaccines-market?kb

Key Segments:

By Vaccine Type: Live-attenuated vaccines, Inactivated vaccines, Others

By Distribution Channel: Hospitals, Retail, Online

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/japanese-encephalitis-vaccines-market?kb

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

New Approvals / Regulatory Status

✦ IXIARO® (inactivated JE vaccine) continues to be the primary licensed JE vaccine in the United States and other global markets, approved for use in adults and children aged less than or Equal to 2 months

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb

Key Clinical Trials & Pipeline Activity (2025-2026)

1. SK bioscience - mRNA JE Vaccine Candidate (GBP560)

✅ SK bioscience has received approval to start Phase 1/2 global clinical trials for its mRNA‐based Japanese encephalitis vaccine candidate, GBP560.

✅ The trial is being conducted in Australia and New Zealand, with interim results expected by 2026.

✅ The goal is to evaluate safety and immune response (immunogenicity) with low, medium, and high doses compared to control, aiming to determine optimal dosage and regimen.

✅ This candidate is part of CEPI's pandemic preparedness efforts and could pave the way for future mRNA vaccines against JE and other emerging pathogens.

2. Vaxxas & SK bioscience - Vaccine Patch Development

✅ A $4.8 M CEPI‐funded program is underway to develop a heat‐stable, microneedle patch formulation of an mRNA JE vaccine, in partnership with Vaxxas.

✅ This approach targets future Phase I studies with a novel delivery method aiming for easier administration and broader access.

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?kb

Contact Us For Exclusive Information: https://www.datamintelligence.com/contact?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Japanese Encephalitis Vaccines Market Poised for Strong Growth with Novel Vaccine Platforms here

News-ID: 4370215 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

U.S. Alzheimer Drugs Market Set for Explosive Growth to USD 8.84 Billion by 2031, Led by North America's 48.2% Global Share | Key Players - Biogen, Eisai, Eli Lilly
U.S. Alzheimer Drugs Market Set for Explosive Growth to USD 8.84 Billion by 2031 …
Leander Texas - The Alzheimer Drugs Market reached US$ 4.46 billion in 2023 and is expected to reach US$ 18.33 billion by 2031, growing at a CAGR of 19.4% during the forecast period 2024-2031. The Alzheimer's drugs market growth is driven by key US-Japan collaborations and approvals, including the JCR Pharma-Acumen Pharmaceuticals partnership to develop a novel blood-brain barrier Alzheimer therapy and expanded use of Eisai/Biogen's lecanemab with new subcutaneous application and
Micro Nuclear Reactors (MNRs) Market to Reach US$ 4,865.85 Million by 2032 at 18.26% CAGR; North America Leads with 35% Share - Key Players: Westinghouse Electric Company, NuScale Power, TerraPower
Micro Nuclear Reactors (MNRs) Market to Reach US$ 4,865.85 Million by 2032 at 18 …
The Micro Nuclear Reactors (MNRs) Market reached US$ 1,434.55 million in 2024 and is projected to reach US$ 4,865.85 million by 2032, growing at a CAGR of 18.26 percent during the forecast period 2025 to 2032. Market growth is driven by increasing demand for reliable, low-carbon energy solutions, supportive government policies promoting clean power generation, and the need for decentralized power in remote and industrial applications. Micro nuclear reactors offer scalable,
Digital Identity Solutions Market Set for Explosive Growth to US$189.92 Billion by 2033, Led by North America's 35.9% Market Share | Key Players - Thales Group, NEC Corporation, IDEMIA
Digital Identity Solutions Market Set for Explosive Growth to US$189.92 Billion …
The Global Digital Identity Solutions Market reached US$35.50 billion in 2023, with a rise to US$42.45 billion in 2024, and is expected to reach US$189.92 billion by 2033, growing at a CAGR of 20.45% during the forecast period 2025-2033. Market growth is driven by escalating cybersecurity threats, surging demand for secure authentication in remote work and e-commerce, and widespread adoption of biometric and blockchain-based verification. Advancements in AI-powered fraud detection, expanding
Iron Ore Mining Market Set for Strong Growth to USD 620.7 Billion by 2031, Led by Asia Pacific's 72.7% Market Share | Key Players - Vale S.A., Rio Tinto, BHP Group
Iron Ore Mining Market Set for Strong Growth to USD 620.7 Billion by 2031, Led b …
Leander Texas - Iron Ore Mining Market reached US$ 330.2 billion in 2022 and is expected to reach US$ 620.7 billion by 2031, growing with a CAGR of 8.2% during the forecast period 2024-2031. The Iron Ore Mining Market's strong growth is boosted by rising infrastructure and steel demand in the U.S. and Japan, coupled with strategic developments like Japanese firms acquiring stakes in global iron ore assets and collaborations with U.S.

All 5 Releases


More Releases for Japanese

Gigago Launches Japanese-Language Website to Support Japanese Tourists Traveling …
Japan, 12th Feb 2026-- Gigago, a global eSIM service provider, has officially launched its Japanese-language website to better serve Japanese tourists seeking convenient, affordable, and reliable mobile connectivity while traveling internationally. The newly published multilingual platform is designed specifically for the Japan tourist market, allowing travelers from Japan to easily purchase and activate eSIM data plans before or during their trips abroad. With the launch of the Japanese site, Gigago strengthens
SOHO Japanese & Sushi Restaurant Sets the Standard for Exceptional Japanese Dini …
Image: https://www.globalnewslines.com/uploads/2025/11/1762169824.jpg SOHO Japanese & Sushi Restaurant continues to earn a reputation as one of the city's premier destinations for authentic Japanese cuisine and fresh sushi creations. Known for its innovative menu, elegant presentation, and dedication to traditional culinary artistry, SOHO brings an elevated dining experience to both locals and visitors seeking refined flavors and atmosphere. Guests searching for Sushi Near Me [http://google.com/maps?cid=13652537627974300363] are consistently drawn to SOHO's expertly crafted dishes that
[Unlimited lessons] Unlimited Japanese Lessons with Native Teachers for $60/Mont …
Dialogplus Group Co., Ltd. launched a new plan at JPLT Online Japanese School, where you can take unlimited Japanese lessons with native teachers for only $60 per month. In addition to standard courses such as the Japanese Language Proficiency Test (JLPT) course and daily English conversation course, you can enjoy unlimited original and unique classes taught by native Japanese teachers. JPLT is the world's largest metaverse Japanese school, providing a free online
How Does Japanese Knotweed Spread?
Japanese knotweed is a fast-growing invasive weed that is feared by UK landowners due to the impact it can have on property values and the damage it can cause if left untreated. Unlike most plants, Japanese knotweed doesn't spread via the seeds. While it does produce seeds, they don't germinate - instead, it's the stem, rhizome and crown that enable the weed to spread. Let's take a closer look at how this
Top-grossing Japanese Mobile Game, “Logres: Japanese RPG” launches Beta Test …
Tokyo, Japan – April 6, 2017 – Marvelous Inc. and Aiming Inc. launches the Beta test of the English version of its top-grossing MMORPG title in Japan, Logres: Japanese RPG. An epic online multiplayer game featuring anime-style graphics and downloaded by millions after its launch in Japan, the Beta test of the English version will be open to Android users in United States, Canada, Australia, United Kingdom, and New Zealand
10-03-2011 | Health & Medicine
FEBICO
Japanese secret to longevity
It is slowly reaching the season of autumn, where temperature difference between night and day is clearly noticeable. This may cause vasoconstriction which may lead to cardiovascular diseases. According to a British research, cardiovascular diseases have a 25% higher percentage of occurring in autumn than in any other seasons. Low temperature may cause instability in the blood vessels, high blood pressure, poor blood circulation and other physiological changes. Coupled with